MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2023-24)
- Udyam number
- UDYAM-TS-02-0019961
Curezen Pharma Private Limited - pharma in Secunderabad, Telangana, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹6.51 Cr
▲ 16% YoY
Net profit · FY 2025
₹21.05 Lakh
Net margin 3.2%
EBITDA · FY 2025
₹25.51 Lakh
EBITDA margin 3.9%
Authorised capital
₹75 Lakh
Registered with MCA
Paid-up capital
₹75 Lakh
Issued & subscribed
Open charges
₹25 Lakh
Secured borrowings
Company age
10 yrs
Est. 2016
Directors on board
3
As per MCA filings
About Curezen Pharma Private Limited
Data last updated:
Curezen Pharma Private Limited is a private limited company based in Secunderabad, Telangana, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 09 July 2016 and has been in existence for over 10 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24230TG2016PTC110785. Its GSTIN is 36AAGCC5429C1ZW (Telangana).
The company has an authorised share capital of ₹75 Lakh and a paid-up capital of ₹75 Lakh. It is led by directors including Raja Narender Madaboina and Madhumathi Kulkarni.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Plot No. 2/A North Portion Ground Floor Vijay Nagar Colony Picket, Secunderabad, Telangana, India – 500026.
As per the financials filed for FY 2025, the company reported a revenue of ₹6.51 Cr, a growth of 16% compared to the previous year. For the same year it recorded a net profit of ₹21.05 Lakh (net margin 3.2%) and EBITDA of ₹25.51 Lakh (EBITDA margin 3.9%). Revenue has grown at a compounded annual rate (CAGR) of 22% over three years and 26% over five years.
As per MCA filings, the company has open charges of ₹25 Lakh on record.
Curezen Pharma Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-TS-02-0019961). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website curezen.com.
Company Details of Curezen Pharma Private Limited
CIN U24230TG2016PTC110785
Registration Number 110785
Incorporation Date 09 July 2016
ROC Hyderabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-TS-02-0019961
Key People
Raja Narender Madaboina Director Madhumathi Kulkarni Director Vani Rajkumar Kulkarni Director Recognitions & Rankings of Curezen Pharma
Contact Details
- EmailLocked
- TelephoneLocked
- Website
- Social Media
- Registered AddressPlot No. 2/A North Portion Ground Floor Vijay Nagar Colony Picket, Secunderabad, Telangana, India – 500026
- IndustryPharma, Drug Formulation & Development
Comprehensive company report
Curezen Pharma Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business Activity of Curezen Pharma Private Limited
The main business activity of Curezen Pharma is trade. In detail, this covers retail trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G2 | Retail Trading | Locked |
Premium access
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Curezen Pharma Private Limited FY 2025 filings available
Curezen Pharma Private Limited reported revenue of ₹6.51 Cr (up 16% YoY) for FY 2025.
Revenue · FY 2025
₹6.51 Cr ▲ 16%
Net profit · FY 2025
₹21.05 Lakh margin 3.2%
EBITDA · FY 2025
₹25.51 Lakh margin 3.9%
Compounded Annual Growth Rate (CAGR) of Curezen Pharma Private Limited
Revenue CAGR growth
1 year
▲ 16%
3 years · compounded
▲ 22%
5 years · compounded
▲ 26%
EBITDA CAGR growth
1 year
▲ 17%
3 years · compounded
▲ 47%
5 years · compounded
▲ 38%
Revenue has grown at a compounded annual rate (CAGR) of 26% over five years, including 16% growth in the latest year. EBITDA rose 17% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Curezen Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹25.51 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹21.05 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Curezen Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 3.9% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 3.2% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Curezen Pharma are in the company report.
Premium access
Financial statements from FY 2017
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Curezen Pharma Private Limited
Curezen Pharma has 3 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Raja Narender Madaboina | Director | 09 Jul 2016 | 10 Years 3 Months | Current |
| Madhumathi Kulkarni | Director | 09 Jul 2016 | 10 Years 3 Months | Current |
| Vani Rajkumar Kulkarni Also directs: Achala Remedies LLP | Director | 09 Jul 2016 | 10 Years 3 Months | Current |
Peer Comparison of Curezen Pharma Private Limited
Curezen Pharma Private Limited is compared with the companies closest to it by revenue in the same principal business activity (Retail Trading). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| F & G Supply Private Limited | ₹6.52 Cr (FY 2025) | •••• | •••• | 47.0% | •••• | Delhi, India |
| Maharshi Industries Private Limited | ₹6.52 Cr (FY 2025) | •••• | •••• | 43.0% | •••• | Gujarat, India |
| Heartlink Medical Solutions Private Limited | ₹6.52 Cr (FY 2025) | •••• | •••• | 108.0% | •••• | Kolkata, West Bengal, India |
| Ceramic City Private Limited | ₹6.52 Cr (FY 2024) | •••• | •••• | 3.0% | •••• | Kolkata, West Bengal, India |
| Artlife Wellness Products Private Limited | ₹6.51 Cr (FY 2024) | •••• | •••• | -20.0% | •••• | New Delhi, Delhi, India |
| Curezen Pharma Private Limited this company | ₹6.51 Cr (FY 2025) | •••• | •••• | 16.0% | •••• | Secunderabad, Telangana, India |
| Skincare Surgipharma Private Limited | ₹6.51 Cr (FY 2024) | •••• | •••• | -3.0% | •••• | Mumbai, Maharashtra, India |
| Salt Lake Wine Pvt Ltd | ₹6.51 Cr (FY 2023) | •••• | •••• | 4.0% | •••• | Kolkata, West Bengal, India |
| New Light Electricals Private Limited | ₹6.51 Cr (FY 2025) | •••• | •••• | 0.0% | •••• | Chandigarh, India |
| Samir Automobiles Private Limited | ₹6.51 Cr (FY 2020) | •••• | •••• | 47.0% | •••• | Guwahati, Assam, India |
| RB Assets & Developers Private Limited | ₹6.51 Cr (FY 2025) | •••• | •••• | -37.0% | •••• | Indore, Madhya Pradesh, India |
Peers are the five companies nearest above and the five nearest below Curezen Pharma by revenue in the same principal business activity (Retail Trading), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Curezen Pharma Private Limited
Curezen Pharma Private Limited is audited by M. MAHENDER REDDY & CO for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| M. MAHENDER REDDY & CO | Locked | Locked | Locked |
Premium access
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Curezen Pharma Private Limited
Premium access
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Curezen Pharma Private Limited
Open charges
₹25 Lakh
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 23 Jan 2018 | City Union Bank Limited | ₹25 Lakh | Open |
Total charge records: 1 View all charges
Employees and EPFO Compliance at Curezen Pharma Private Limited
Employment history and EPFO contributions of people linked to Curezen Pharma.
Premium access
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Curezen Pharma Private Limited
Curezen Pharma Private Limited has 3 board changes on record since 2016: 3 appointments. The latest: Madhumathi Kulkarni was appointed as Director on 09 Jul 2016.
AGM
Curezen Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Curezen Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad.
Charges
A charge with City Union Bank Limited of Rs. 25.00 Lakh registered on 23 Jan 2018 with Charge ID 100160012 was modified on 15 Mar 2019.
Charges
A charge with City Union Bank Limited amounted to Rs. 25.00 Lakh with Charge ID 100160012 was registered on 23 Jan 2018.
Appointed
Madhumathi Kulkarni was appointed as Director.
Appointed
Raja Narender Madaboina was appointed as Director.
Appointed
Vani Rajkumar Kulkarni was appointed as Director.
Incorporation
09 Jul 2016
Curezen Pharma Private Limited was registered on 09 Jul 2016 with Roc Hyderabad & aged 10 years 3 months as per MCA records.
Credit Ratings, Litigation & Regulatory Alerts for Curezen Pharma Private Limited
Premium access
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Curezen Pharma Private Limited
Premium access
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Curezen Pharma Private Limited
Premium access
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Curezen Pharma Private Limited
Curezen Pharma has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AAGCC5429C1ZW | Telangana | Active | 01 Jul 2017 |
Premium access
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Curezen Pharma Private Limited
Premium access
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Curezen Pharma Private Limited
Curezen Pharma is an active private limited company based in Secunderabad, Telangana, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 09 July 2016 (10+ years old) and is registered under CIN U24230TG2016PTC110785.
Curezen Pharma reported revenue of ₹6.51 Cr for FY 2025 (up 16% YoY).
Curezen Pharma has 3 current directors:
- Raja Narender Madaboina - Director
- Madhumathi Kulkarni - Director
- Vani Rajkumar Kulkarni - Director
Curezen Pharma reported a net profit of ₹21.05 Lakh (net margin 3.2%) and EBITDA of ₹25.51 Lakh (EBITDA margin 3.9%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Curezen Pharma is 22% over three years and 26% over five years. In the latest year (FY 2025) revenue rose 16%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Curezen Pharma is 36AAGCC5429C1ZW, registered in Telangana.
The CIN (Corporate Identification Number) of Curezen Pharma is U24230TG2016PTC110785. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Curezen Pharma was incorporated on 09 July 2016, making it 10+ years old. It is registered with the Registrar of Companies, Hyderabad.
The peers of Curezen Pharma by revenue are F & G Supply Private Limited, Maharshi Industries Private Limited, Heartlink Medical Solutions Private Limited, Ceramic City Private Limited, Artlife Wellness Products Private Limited and 5 more, all in the same principal business activity (Retail Trading).
Madhumathi Kulkarni was appointed as Director on 09 Jul 2016. Raja Narender Madaboina was appointed as Director on 09 Jul 2016. Vani Rajkumar Kulkarni was appointed as Director on 09 Jul 2016.
Yes, Curezen Pharma is registered as a micro enterprise under Udyam registration (number: UDYAM-TS-02-0019961).